Page last updated: 2024-09-03

n-hydroxysuccinimidyl digoxigenin-3-o-methylcarbonyl-epsilon-aminocaproate and busulfan

n-hydroxysuccinimidyl digoxigenin-3-o-methylcarbonyl-epsilon-aminocaproate has been researched along with busulfan in 1 studies

Compound Research Comparison

Studies
(n-hydroxysuccinimidyl digoxigenin-3-o-methylcarbonyl-epsilon-aminocaproate)
Trials
(n-hydroxysuccinimidyl digoxigenin-3-o-methylcarbonyl-epsilon-aminocaproate)
Recent Studies (post-2010)
(n-hydroxysuccinimidyl digoxigenin-3-o-methylcarbonyl-epsilon-aminocaproate)
Studies
(busulfan)
Trials
(busulfan)
Recent Studies (post-2010) (busulfan)
10044,9676451,426

Protein Interaction Comparison

ProteinTaxonomyn-hydroxysuccinimidyl digoxigenin-3-o-methylcarbonyl-epsilon-aminocaproate (IC50)busulfan (IC50)
Matrix metalloproteinase-9Homo sapiens (human)5.215

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Hazuku, T; Kawano, K; Kodama, Y; Maruyama, R; Miyazaki, Y; Ohtsuka, E; Saburi, M; Sakata, M; Takata, H; Urabe, S; Wada, J1

Other Studies

1 other study(ies) available for n-hydroxysuccinimidyl digoxigenin-3-o-methylcarbonyl-epsilon-aminocaproate and busulfan

ArticleYear
[Busulfan/thiotepa followed by autologous peripheral blood stem cell transplantation for refractory diffuse large B-cell lymphoma accompanied by hypopyon].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2022, Volume: 63, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cyclophosphamide; Doxorubicin; Humans; Lymphadenopathy; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Rituximab; Thiotepa; Transplantation, Autologous; Vincristine

2022